Von Willebrand Factor A Domain Containing 5A (VWA5A) Peptide
-
- Target See all VWA5A products
- VWA5A (Von Willebrand Factor A Domain Containing 5A (VWA5A))
- Origin
- Human, Mouse, Monkey, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-VWA5A Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- VWA5A (Von Willebrand Factor A Domain Containing 5A (VWA5A))
- Synonyms
- VWA5A Peptide, LOH11CR2A Peptide, MGC68953 Peptide, loh11cr2a Peptide, BCSC-1 Peptide, BCSC1 Peptide, 5830475I06Rik Peptide, AW552491 Peptide, E130119J22 Peptide, Loh11cr2a Peptide, masa-1 Peptide, loss of heterozygosity, 11, chromosomal region 2, gene A Peptide, von Willebrand factor A domain containing 5A Peptide, von Willebrand factor A domain containing 5A S homeolog Peptide, LOH11CR2A Peptide, VWA5A Peptide, vwa5a.S Peptide, vwa5a Peptide, Vwa5a Peptide
- Background
- BCSC1, LOH11CR2A, von Willebrand factor A domain-containing protein 5A, Breast cancer suppressor candidate 1, BCSC-1, Loss of heterozygosity 11 chromosomal region 2 gene A protein
- Gene ID
- 4013, 67776
- UniProt
- O00534, Q99KC8
-